PMC:7247483 / 2878-3099 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T5","span":{"begin":3,"end":5},"obj":"https://glytoucan.org/Structures/Glycans/G93424OB"},{"id":"T6","span":{"begin":128,"end":130},"obj":"https://glytoucan.org/Structures/Glycans/G93424OB"}],"text":"G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P \u003e 0.05) (Table 1 ). However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 5"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":58,"end":66},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P \u003e 0.05) (Table 1 ). However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 5"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":131,"end":135},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P \u003e 0.05) (Table 1 ). However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 5"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":3,"end":5},"obj":"Chemical"},{"id":"T24","span":{"begin":11,"end":13},"obj":"Chemical"},{"id":"T26","span":{"begin":128,"end":130},"obj":"Chemical"}],"attributes":[{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A23","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_18291"},{"id":"A25","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_28808"},{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A27","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"}],"text":"G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P \u003e 0.05) (Table 1 ). However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 5"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":3,"end":5},"obj":"GlycoEpitope"},{"id":"T6","span":{"begin":128,"end":130},"obj":"GlycoEpitope"}],"attributes":[{"id":"A5","pred":"glyco_epitope_db_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0510"},{"id":"A6","pred":"glyco_epitope_db_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P \u003e 0.05) (Table 1 ). However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 5"}